(EPD) Enterprise Products Partners - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US2937921078
Stock: Natural Gas, Liquids, Crude Oil, Petrochemicals
Total Rating 55
Risk 59
Buy Signal 0.22
| Risk 5d forecast | |
|---|---|
| Volatility | 15.2% |
| Relative Tail Risk | 0.19% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.99 |
| Alpha | 12.53 |
| Character TTM | |
|---|---|
| Beta | 0.396 |
| Beta Downside | 0.537 |
| Drawdowns 3y | |
|---|---|
| Max DD | 15.40% |
| CAGR/Max DD | 1.44 |
EPS (Earnings per Share)
Revenue
Description: EPD Enterprise Products Partners March 04, 2026
Enterprise Products Partners LP (EPD) is a midstream energy company. This sector focuses on transporting and processing energy commodities, acting as a crucial link between production and consumption.
EPD operates across four segments: NGL Pipelines & Services, Crude Oil Pipelines & Services, Natural Gas Pipelines & Services, and Petrochemical & Refined Products Services. Midstream companies often generate revenue through stable, fee-based contracts for their infrastructure.
The NGL Pipelines & Services segment includes natural gas processing, NGL pipelines, fractionation, storage, and marine terminals. The Crude Oil Pipelines & Services segment manages crude oil pipelines, storage, marine terminals, and marketing, utilizing a fleet of tank trucks.
The Natural Gas Pipelines & Services segment focuses on gathering, treating, and transporting natural gas, including the operation of underground salt dome storage facilities. The Petrochemical & Refined Products Services segment operates propylene fractionation, butane isomerization, and octane enhancement facilities, alongside refined products pipelines, terminals, and marketing.
For a deeper dive into EPDs financial performance and market position, consider exploring its profile on ValueRay.
Headlines to watch out for
Commodity price volatility impacts NGL, crude oil, and natural gas revenue | Regulatory changes for pipeline operations increase compliance costs | Industrial demand for petrochemicals drives processing and transportation volumes | Interest rate fluctuations affect financing costs for infrastructure projects | Global energy demand shifts influence pipeline utilization and expansion opportunities
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income: 5.80b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.02 > 0.02 and ΔFCF/TA -2.32 > 1.0 |
| NWC/Revenue: 1.00% < 20% (prev -0.08%; Δ 1.08% < -1%) |
| CFO/TA 0.11 > 3% & CFO 8.53b > Net Income 5.80b |
| Net Debt (656.0m) to EBITDA (9.92b): 0.07 < 3 |
| Current Ratio: 1.04 > 1.5 & < 3 |
| Outstanding Shares: last quarter (2.19b) vs 12m ago -0.23% < -2% |
| Gross Margin: 13.62% > 18% (prev 0.13%; Δ 1350 % > 0.5%) |
| Asset Turnover: 67.84% > 50% (prev 72.85%; Δ -5.02% > 0%) |
| Interest Coverage Ratio: 5.21 > 6 (EBITDA TTM 9.92b / Interest Expense TTM 1.40b) |
Altman Z''
| A: 0.01 (Total Current Assets 13.36b - Total Current Liabilities 12.83b) / Total Assets 77.90b |
| B: error (Retained Earnings missing) |
| C: 0.09 (EBIT TTM 7.30b / Avg Total Assets 77.53b) |
| D: 1.26 (Book Value of Equity 59.91b / Total Liabilities 47.41b) |
Beneish M
| DSRI: 0.75 (Receivables 6.50b/9.24b, Revenue 52.60b/56.22b) |
| GMI: 0.94 (GM 13.62% / 12.85%) |
| AQI: none (AQ_t none / AQ_t-1 none) |
| SGI: 0.94 (Revenue 52.60b / 56.22b) |
| TATA: -0.04 (NI 5.80b - CFO 8.53b) / TA 77.90b) |
| Beneish M-Score: cannot calculate (missing components) |
What is the price of EPD shares?
As of March 08, 2026, the stock is trading at USD 37.57 with a total of 4,413,803 shares traded.
Over the past week, the price has changed by +3.96%, over one month by +7.62%, over three months by +16.74% and over the past year by +22.87%.
Over the past week, the price has changed by +3.96%, over one month by +7.62%, over three months by +16.74% and over the past year by +22.87%.
Is EPD a buy, sell or hold?
Enterprise Products Partners has received a consensus analysts rating of 4.16.
Therefore, it is recommended to buy EPD.
- StrongBuy: 9
- Buy: 4
- Hold: 6
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the EPD price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 36.8 | -2% |
| Analysts Target Price | 36.8 | -2% |
EPD Fundamental Data Overview March 05, 2026
P/E Trailing = 14.0526
P/E Forward = 13.245
P/S = 1.5388
P/B = 2.7322
P/EG = 2.1288
Revenue TTM = 52.60b USD
EBIT TTM = 7.30b USD
EBITDA TTM = 9.92b USD
Long Term Debt = 31.11b USD (from longTermDebt, two quarters ago)
Short Term Debt = 1.62b USD (from shortTermDebt, last quarter)
Debt = 1.62b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 656.0m USD (from netDebt column, last quarter)
Enterprise Value = 81.59b USD (80.94b + Debt 1.62b - CCE 969.0m)
Interest Coverage Ratio = 5.21 (Ebit TTM 7.30b / Interest Expense TTM 1.40b)
EV/FCF = 45.48x (Enterprise Value 81.59b / FCF TTM 1.79b)
FCF Yield = 2.20% (FCF TTM 1.79b / Enterprise Value 81.59b)
FCF Margin = 3.41% (FCF TTM 1.79b / Revenue TTM 52.60b)
Net Margin = 11.03% (Net Income TTM 5.80b / Revenue TTM 52.60b)
Gross Margin = 13.62% ((Revenue TTM 52.60b - Cost of Revenue TTM 45.43b) / Revenue TTM)
Gross Margin QoQ = 14.51% (prev 13.78%)
Tobins Q-Ratio = 1.05 (Enterprise Value 81.59b / Total Assets 77.90b)
Interest Expense / Debt = 23.08% (Interest Expense 375.0m / Debt 1.62b)
Taxrate = 0.24% (4.00m / 1.66b)
NOPAT = 7.28b (EBIT 7.30b * (1 - 0.24%))
Current Ratio = 1.04 (Total Current Assets 13.36b / Total Current Liabilities 12.83b)
Debt / Equity = 0.05 (Debt 1.62b / totalStockholderEquity, last quarter 30.10b)
Debt / EBITDA = 0.07 (Net Debt 656.0m / EBITDA 9.92b)
Debt / FCF = 0.37 (Net Debt 656.0m / FCF TTM 1.79b)
Total Stockholder Equity = 29.32b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.48% (Net Income 5.80b / Total Assets 77.90b)
RoE = 19.78% (Net Income TTM 5.80b / Total Stockholder Equity 29.32b)
RoCE = 12.08% (EBIT 7.30b / Capital Employed (Equity 29.32b + L.T.Debt 31.11b))
RoIC = 11.81% (NOPAT 7.28b / Invested Capital 61.69b)
WACC = 7.68% (E(80.94b)/V(82.56b) * Re(7.37%) + D(1.62b)/V(82.56b) * Rd(23.08%) * (1-Tc(0.00)))
Discount Rate = 7.37% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -0.16%
[DCF] Terminal Value 77.10% ; FCFF base≈2.50b ; Y1≈2.17b ; Y5≈1.72b
[DCF] Fair Price = 15.08 (EV 33.29b - Net Debt 656.0m = Equity 32.63b / Shares 2.16b; r=7.68% [WACC]; 5y FCF grow -16.29% → 2.90% )
EPS Correlation: 53.20 | EPS CAGR: 6.75% | SUE: 1.54 | # QB: 1
Revenue Correlation: -15.50 | Revenue CAGR: 1.57% | SUE: 0.40 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.66 | Chg7d=-0.022 | Chg30d=-0.022 | Revisions Net=-1 | Analysts=2
EPS current Year (2026-12-31): EPS=2.76 | Chg7d=-0.087 | Chg30d=-0.102 | Revisions Net=-4 | Growth EPS=+3.1% | Growth Revenue=+0.2%
EPS next Year (2027-12-31): EPS=3.06 | Chg7d=+0.061 | Chg30d=+0.041 | Revisions Net=-1 | Growth EPS=+10.8% | Growth Revenue=+6.7%
[Analyst] Revisions Ratio: -1.00 (0 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 0.8% (Discount Rate 7.9% - Earnings Yield 7.1%)
[Growth] Growth Spread = +9.9% (Analyst 10.8% - Implied 0.8%)
P/E Forward = 13.245
P/S = 1.5388
P/B = 2.7322
P/EG = 2.1288
Revenue TTM = 52.60b USD
EBIT TTM = 7.30b USD
EBITDA TTM = 9.92b USD
Long Term Debt = 31.11b USD (from longTermDebt, two quarters ago)
Short Term Debt = 1.62b USD (from shortTermDebt, last quarter)
Debt = 1.62b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 656.0m USD (from netDebt column, last quarter)
Enterprise Value = 81.59b USD (80.94b + Debt 1.62b - CCE 969.0m)
Interest Coverage Ratio = 5.21 (Ebit TTM 7.30b / Interest Expense TTM 1.40b)
EV/FCF = 45.48x (Enterprise Value 81.59b / FCF TTM 1.79b)
FCF Yield = 2.20% (FCF TTM 1.79b / Enterprise Value 81.59b)
FCF Margin = 3.41% (FCF TTM 1.79b / Revenue TTM 52.60b)
Net Margin = 11.03% (Net Income TTM 5.80b / Revenue TTM 52.60b)
Gross Margin = 13.62% ((Revenue TTM 52.60b - Cost of Revenue TTM 45.43b) / Revenue TTM)
Gross Margin QoQ = 14.51% (prev 13.78%)
Tobins Q-Ratio = 1.05 (Enterprise Value 81.59b / Total Assets 77.90b)
Interest Expense / Debt = 23.08% (Interest Expense 375.0m / Debt 1.62b)
Taxrate = 0.24% (4.00m / 1.66b)
NOPAT = 7.28b (EBIT 7.30b * (1 - 0.24%))
Current Ratio = 1.04 (Total Current Assets 13.36b / Total Current Liabilities 12.83b)
Debt / Equity = 0.05 (Debt 1.62b / totalStockholderEquity, last quarter 30.10b)
Debt / EBITDA = 0.07 (Net Debt 656.0m / EBITDA 9.92b)
Debt / FCF = 0.37 (Net Debt 656.0m / FCF TTM 1.79b)
Total Stockholder Equity = 29.32b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.48% (Net Income 5.80b / Total Assets 77.90b)
RoE = 19.78% (Net Income TTM 5.80b / Total Stockholder Equity 29.32b)
RoCE = 12.08% (EBIT 7.30b / Capital Employed (Equity 29.32b + L.T.Debt 31.11b))
RoIC = 11.81% (NOPAT 7.28b / Invested Capital 61.69b)
WACC = 7.68% (E(80.94b)/V(82.56b) * Re(7.37%) + D(1.62b)/V(82.56b) * Rd(23.08%) * (1-Tc(0.00)))
Discount Rate = 7.37% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -0.16%
[DCF] Terminal Value 77.10% ; FCFF base≈2.50b ; Y1≈2.17b ; Y5≈1.72b
[DCF] Fair Price = 15.08 (EV 33.29b - Net Debt 656.0m = Equity 32.63b / Shares 2.16b; r=7.68% [WACC]; 5y FCF grow -16.29% → 2.90% )
EPS Correlation: 53.20 | EPS CAGR: 6.75% | SUE: 1.54 | # QB: 1
Revenue Correlation: -15.50 | Revenue CAGR: 1.57% | SUE: 0.40 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.66 | Chg7d=-0.022 | Chg30d=-0.022 | Revisions Net=-1 | Analysts=2
EPS current Year (2026-12-31): EPS=2.76 | Chg7d=-0.087 | Chg30d=-0.102 | Revisions Net=-4 | Growth EPS=+3.1% | Growth Revenue=+0.2%
EPS next Year (2027-12-31): EPS=3.06 | Chg7d=+0.061 | Chg30d=+0.041 | Revisions Net=-1 | Growth EPS=+10.8% | Growth Revenue=+6.7%
[Analyst] Revisions Ratio: -1.00 (0 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 0.8% (Discount Rate 7.9% - Earnings Yield 7.1%)
[Growth] Growth Spread = +9.9% (Analyst 10.8% - Implied 0.8%)